Molecular Tumor Board (MTB)

Our Molecular Tumor Board is a multidisciplinary team of oncologists, geneticists, bioinformaticians, and other clinical experts, that meets weekly to individually discuss the patients that have enrolled in the BOB trial. To guide the discussion, we use the MTB Portal (MTBP), which generates individual patient reports that contain their clinical and molecular data. The MTBP interprets the molecular alterations that are functionally relevant for the patient’s tumor and matches them with biomarkers of disease diagnosis, prognosis and drug response to deliver personalized cancer therapy options. It also matches the results to the ongoing modules within the BOB trial, facilitating the clinical decision and the inclusion of patients in the trial.